Formation of specific t-cell and humoral immunity in unvaccinated and vaccinated children with pertussis
- Authors: Fedorova I.M.1, Popova O.P.1,2, Blyakher M.S.1, Koteleva S.I.1, Skirda T.A.1, Kapustin I.V.1, Ramazanova Z.K.1, Tulskaya E.A.1, Sandalova S.V.1, Odintsov E.E.1, Shvetsova J.V.3
-
Affiliations:
- G.N. Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology of Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
- Russian Medical Academy of Continuous Professional Education, Ministry of Health of Russia
- Infectious Clinical Hospital № 1 of the Moscow Healthcare Department
- Issue: Vol 14, No 1 (2024)
- Pages: 36-42
- Section: Original Investigations
- URL: https://journals.eco-vector.com/2226-6976/article/view/630512
- ID: 630512
Cite item
Abstract
Objective. Evaluation of the relationship between the formation of antigen (AG) – specific T-cell and humoral immunity and its cytokine regulation in the dynamics of pertussis in children.
Materials and methods. 100 children with pertussis were examined at 2–5 weeks of disease and during the period of convalescence. The balance of IFN-γ and IL-4 cytokines in the blood was compared with the dynamics of the specific immune response to B. pertussis antigens. The humoral response was assessed by enzyme immunoassay using Ridascreen test systems, and the T-cell response was assessed by the proliferation of lymphocytes isolated from the blood of patients after incubation on plates from the same test systems.
Results. In 69–92% of unvaccinated children, antigen-specific T-cells are detected from the 2nd to 12th week from the onset of the disease with a temporary sharp decrease in indicators at the 5–6th week. In vaccinated children with pertussis, the immune response develops as a secondary one, but memory T cells are found in no more than 67% of patients.
Conclusion. The nature of cytokine regulation of antibody formation in the dynamics of pertussis is reflected in the process of formation of memory T-cells and depends on the vaccine history.
Full Text

About the authors
Irina M. Fedorova
G.N. Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology of Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Author for correspondence.
Email: vestnik-07@mail.ru
ORCID iD: 0000-0002-0335-2752
Cand. Med. Sci., Leading Researcher, Department of Immunology
Russian Federation, MoscowOlga P. Popova
G.N. Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology of Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being; Russian Medical Academy of Continuous Professional Education, Ministry of Health of Russia
Email: doctorpopova@yandex.ru
ORCID iD: 0000-0002-1772-5978
MD, Professor, Department of Children’s Infectious Diseases, Russian Medical Academy of Continuous Professional Education, Ministry of Health of Russia; Leading Researcher, Department of Immunology, G.N. Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Russian Federation, Moscow; MoscowMaria S. Blyakher
G.N. Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology of Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Email: maria.s.b@bk.ru
ORCID iD: 0000-0003-3480-6873
MD, Professor, Head, Laboratory of the Immunology Department
Russian Federation, MoscowSvetlana I. Koteleva
G.N. Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology of Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Email: felileo@yandex.ru
ORCID iD: 0000-0003-1878-2234
Cand. Med. Sci., Leading Researcher, Department of Immunology
Russian Federation, MoscowTatyana A. Skirda
G.N. Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology of Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Email: t.skirda@mail.ru
ORCID iD: 0000-0003-4140-1014
Cand. Med. Sci., Leading Researcher, Laboratory of Coccal Infections of the Epidemiological Department
Russian Federation, MoscowIvan V. Kapustin
G.N. Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology of Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Email: vano-kapusta@mail.ru
ORCID iD: 0000-0001-6191-260X
Cand. Med. Sci., Leading Researcher, Laboratory of Coccal Infections of the Epidemiological Department
Russian Federation, MoscowZarema K. Ramazanova
G.N. Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology of Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Email: rzarema@mail.ru
ORCID iD: 0000-0002-9314-3312
Cand. Med. Sci, Leading Researcher, Department of Immunology
Russian Federation, MoscowElena A. Tulskaya
G.N. Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology of Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Email: etul@mail.ru
ORCID iD: 0000-0003-1969-4009
Cand. Med. Sci., Leading Researcher, Laboratory of Coccal Infections of the Epidemiological Department
Russian Federation, MoscowSvetlana V. Sandalova
G.N. Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology of Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Email: s.sandalova74@mail.ru
ORCID iD: 0000-0002-4548-9888
Researcher, Department of Immunology
Russian Federation, MoscowEvgeniy E. Odintsov
G.N. Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology of Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Email: evgenyodin@yahoo.com
ORCID iD: 0000-0001-5895-2520
Cand. Med. Sci., Senior Researcher, Department of Immunology
Russian Federation, MoscowJuliya V. Shvetsova
Infectious Clinical Hospital № 1 of the Moscow Healthcare Department
Email: uliashvetsova1983@gmail.com
Infectious Disease Physician, Pediatrician of the 3rd Pediatric Department
Russian Federation, MoscowReferences
- Van Twillert I., Han W.G.H., van Els C.A.C.M. Waning and aging of cellular immunity to Bordetella pertussis. Pathog. Dis. 2015; 73(8): ftv071. doi: 10.1093/femspd/ftv071
- Lambert E.E., Buisman A.M., van Els C.A.C.M. Superior B. pertussis specific CD4+ T-cell immunity imprinted by natural infection. Adv. Exp. Med. Biol. 2019; 1183: 81–98. doi: 10.1007/5584_2019_405.
- Ausiello C.M., Mascart F. Corbiere V., Fedele G. Human immune responses to pertussis vaccines. Adv. Exp. Med. Biol. 2019; 1183: 99–113. doi: 10.1007/5584_2019_406.
- Debrie A.S., Coutte L., Raze D., Mooi F., Alexander F., Gorringe A., et al. Construction and evaluation of Bordetella pertussis live attenuated vaccine strain BPZE1 producing Fim3 Vaccine. 2018; 36(11): 1345–52. doi: 10.1016/j.vaccine.2018.02.017
- Saso A., Kampmann B., Roetynck S. Vaccine-induced cellular immunity against Bordetella pertussis: harnessing lessons from animal and human studies to improve design and testing of novel pertussis vaccines. Vaccines (Basel). 2021; 9(8): Article 877. doi: 10.3390/vaccines9080877
- Diavatopoulos. D.A., Edwards K. M. What is wrong with pertussis vaccine immunity? Why immunological memory to pertussis is failing? Cold Spring Harb. Perspect. Biol. 2017; 9(12): a029553. doi: 10.1101/cshperspect.a029553
- Allen A.C., Mills K.H. Improved pertussis vaccines based on adjuvants that induce cell-mediated immunity. Expert Rev. Vaccines 2014; 13(10): 1253–64. doi: 10.1586/14760584.2014.936391
- Weaver K.L., Blackwood C.B., Horspool A.M., Pyles G.M., Sen-Kilic E., Grayson E.M. et al. Long-term analysis of pertussis vaccine immunity to identify potential markers of vaccine-induced memory associated with whole cell but not acellular pertussis immunization in mice. Front Immunol. 2022; 13: Article 838504. doi: 10.3389/fimmu.2022.838504. eCollection 2022
- Медкова А.Ю., Лиджиева А.А., Семин Е.Г., Синяшина Л.Н., Сюндюкова Р.А., Снегирева Н.А. и др. Иммуногенность препарата «Живая вакцина интраназального применения для профилактики коклюша» (ГамЖВК) при однократном применении у здоровых добровольцев. Журнал микробиологии, эпидемиологии и иммунобиологии 2021; 98(6): 706–20. doi: 10.36233/0372-9311-194
- Medkova A.Yu., Lidzhiyeva A.A., Semin E.G., Sinyashina L.N., Syundyukova R.A., Snegireva N.A. et al. [Immunogenicity of the drug «Live intranasal vaccine for the prevention of pertussis» (GamLPV) with a single use in healthy volunteers]. Journal of microbiology, epidemiology and immunobiology 2021; 98(6): 706–20. (In Russ.). doi: 10.36233/0372-9311-194
- Han W.G.H., Helm K., Poelen M.M.C., Otten H.G., van Els C.A.C.M. Ex vivo peptide-MHC II tetramer analysis reveals distinct end-differentiation patterns of human pertussis-specific CD4+ T-cells following clinical infection. Clin. Immunol. 2015; 157(2): 205–15. doi: 10.1016/j.clim.2015.02.009.
- Mascart F., Verscheure V., Malfroot A., Hainaut M., Piérard D., Temerman S. et al. Bordetella pertussis infection in 2-month-old infants promotes type 1 T-cell responses. J. Immunol. 2003; 170(3): 1504–9. doi: 10.4049/jimmunol.170.3.1504
- Бабаченко И.В., Ярв Н.Э., Калинина Н.М., Ценева Г.Я. Особенности клеточного звена и цитокинового профиля иммунного ответа у детей, больных коклюшем. Цитокины и воспаление 2006; 5(4): 3–9. https://elibrary.ru/item.asp?id=22840191
- Babachenko I.V., Jarv N.E., Kalinina N.I., Tseneva G.Y. [Peculiarities of cellular immunity and cytokine response in the children with the whooping cough]. Cytokiny i vospalenie 2006; 5(4): 3–9. (In Russ.). https://elibrary.ru/item.asp?id=22840191
- Краснова Е.И., Панасенко Л.M., Ефремов A.B. Содержание противовоспалительных и иммунорегуляторных цитокинов в сыворотке крови больных коклюшем. Инфекционные болезни 2005; 3(1): 36–9.
- Krasnova Ye.I., Panasenko L.M., Yefremov A.B. [Concentration of anti-inflammatory and immunoregulatory cytokines in the blood serum of patients with whooping cough]. Infectious Diseases 2005; 3(1): 36–9. (In Russ.).
- Попова О.П., Скирда Т.А., Федорова И.М., Котелева С.И. Особенности специфического гуморального ответа и цитокиновой регуляции при коклюше у детей. Эпидемиол. и инфекц. бол. 2015; 20(5): 42–8.
- Popova O.P., Skirda T.A., Fedorova I.M., Koteleva S.I. [Features of the specific humoral response and cytokine regulation in whoopin cough in children]. Epidemiologу and Infectious Diseases 2015; 20(5): 42–8. (In Russ.).
- Федорова И.М., Котелева С.И., Попова О.П. Антиген-специфическая активность лимфоцитов при коклюше у детей. Российский аллергологический журнал 2012; 1(вып. 1): 320–2.
- Fedorova I.M., Koteleva S.I., Popova O.P. [Lymphocyte antigen specific proliferative activity during whooping cough in children]. Russian Journal of Allergy 2012; 1(issue 1): 320–2. (In Russ.).
- Бляхер М.С., Федорова И.М., Котелева С.И., Капустин И.В., Лопатина Т.К., Кукушкина Е.А. и др. Антигенная активация лимфоцитов при разных видах инфекционных заболеваний. Медицинская иммунология 2015; 17(спец. вып.): 154.
- Blyakher M.S., Fedorova I.M., Koteleva S.I., Kapustin I.V., Lopatina T.K., Kukushkina Ye.A. et al. [Antigenic activation of lymphocytes in various types of infectious diseases]. Medical Immunology 2015; 17(Special Issue): 154.
- Попова О.П., Федорова И.М., Котелева С.И. Особенности цитокинового профиля у детей, больных коклюшем. Эпидемиол. и инфекц. бол. 2013; (5): 33–7. https://cyberleninka.ru/article/n/15779177
- Popova O.P., Fedorova I.M., Koteleva S.I. [Features of the cytokine profile in children suffering from pertussis]. Epidemiologу and Infectious Diseases 2013; (5): 33–7. (In Russ.).
- Van der Lee S., Hendrikx L.H., Sanders E.A.M., Berbers G.A.M., Buisman A.M. Whole-cell or acellular pertussis primary immunizations in infancy determines adolescent cellular immune profiles. Front Immunol. 2018; (9): Article 51. doi: 10.3389/fimmu.2018.00051. eCollection 2018
- Borkner L., Misiak A., Wilk M.M., Mills K.H.G. Azithromycin clears Bordetella pertussis infection in mice but also modulates innate and adaptive immune responses and T-cell memory. Front Immunol. 2018; (9): Article 1764. doi: 10.3389/fimmu.2018.01764. eCollection 2018
Supplementary files
